Publicaciones en las que colabora con María José García Velloso (46)

2023

  1. Disseminated lymphadenopathy during chemotherapy for squamous cell lung carcinoma

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 7, pp. 438-440

  2. Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients

    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, Vol. 29, Núm. 10, pp. 1100-1108

2022

  1. 11C-Methionine PET/CT in Assessment of Multiple Myeloma Patients: Comparison to 18F-FDG PET/CT and Prognostic Value

    International Journal of Molecular Sciences, Vol. 23, Núm. 17

2021

  1. Diagnostic accuracy of visual analysis versus dual time-point imaging with 18F-FDG PET/CT for the characterization of indeterminate pulmonary nodules with low uptake

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 40, Núm. 3, pp. 155-160

  2. Early imaging and molecular changes with neoadjuvant bevacizumab in stage ii/iii breast cancer

    Cancers, Vol. 13, Núm. 14

  3. Ultra-low dose whole-body CT for attenuation correction in a dual tracer PET/CT protocol for multiple myeloma

    Physica Medica, Vol. 84, pp. 1-9

2020

  1. Article18 f-fdg and11 c-methionine pet/ct in newly diagnosed multiple myeloma patients: Comparison of volume-based pet biomarkers

    Cancers, Vol. 12, Núm. 4

  2. FDG PET/CT in colorectal cancer

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 39, Núm. 1, pp. 57-66

  3. The utility of ADC value in diffusion-weighted whole-body MRI in the follow-up of patients with multiple myeloma. Correlation study with 18F-FDG PET-CT

    European Journal of Radiology, Vol. 133

2018

  1. Assessment of metabolic patterns and new antitumoral treatment in osteosarcoma xenograft models by [ 18 F]FDG and sodium [ 18 F]fluoride PET

    BMC Cancer, Vol. 18, Núm. 1

  2. Evolution of Nuclear Medicine in the diagnosis and treatment of prostate cancer

    Revista Espanola de Medicina Nuclear e Imagen Molecular

  3. Significant dose reduction is feasible in FDG PET/CT protocols without compromising diagnostic quality

    Physica Medica, Vol. 46, pp. 134-139

2017

  1. 11C-Methionine-PET in multiple myeloma: A combined study from two different institutions

    Theranostics, Vol. 7, Núm. 11, pp. 2956-2964

  2. Effective dose estimation for oncological and neurological PET/CT procedures

    EJNMMI Research, Vol. 7, Núm. 1

  3. MRI fused with prone FDG PET/CT improves the primary tumour staging of patients with breast cancer

    European Radiology, Vol. 27, Núm. 8, pp. 3190-3198

  4. Non-invasive in vivo imaging of cardiac stem/progenitor cell biodistribution and retention after intracoronary and intramyocardial delivery in a swine model of chronic ischemia reperfusion injury

    Journal of Translational Medicine, Vol. 15, Núm. 1

2016

  1. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT

    Lung Cancer, Vol. 97, pp. 81-86

2015

  1. Lung Cancer Screening: Fourteen Year Experience of the Pamplona Early Detection Program (P-IELCAP)

    Archivos de Bronconeumologia, Vol. 51, Núm. 4, pp. 169-176

2014

  1. Erratum to: Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer

    European Journal of Nuclear Medicine and Molecular Imaging

  2. PET optimization for improved assessment and accurate quantification of 90Y-microsphere biodistribution after radioembolization

    Medical Physics, Vol. 41, Núm. 9